Best Buy is the stock of the summer — plus 2 more encouraging reports

Best Buy is the stock of the summer — plus 2 more encouraging reports

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market check: The S & P 500 is limping into the long weekend, giving back most of its earlier gains in the session, though the index … Read more

Stock Markets: Everyone’s waiting for Nvidia

Stock Markets: Everyone’s waiting for Nvidia

Traders work on the floor of the New York Stock Exchange (NYSE) during morning trading in New York on August 23, 2024. Angela Weiss | AFP | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, … Read more

It’s been nearly a year since we took profits in Eli Lilly. We’re overdue for another trim

It’s been nearly a year since we took profits in Eli Lilly. We’re overdue for another trim

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks were essentially flat Tuesday after the S & P 500 and Nasdaq kicked the week off in the red. Higher Treasury yields are a wrinkle in Tuesday’s action, making … Read more

Eli Lilly releases new, cheaper form of weight loss drug

Eli Lilly releases new, cheaper form of weight loss drug

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for … Read more

What’s likely to move the market in the next trading session

What’s likely to move the market in the next trading session

U.S. Federal Reserve Chair Jerome Powell speaks at a news conference on interest rates, the economy and monetary policy actions on June 15, 2022. Olivier Douliery- | Afp | Getty Images Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for … Read more

CNBC Daily Open: A ‘crazy’ summer

CNBC Daily Open: A ‘crazy’ summer

Traders work on the floor of the New York Stock Exchange during morning trading on August 20, 2024 in New York City. Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no … Read more

CNBC Daily Open: ‘Crazy’ summer

CNBC Daily Open: ‘Crazy’ summer

Traders work on the floor of the New York Stock Exchange during morning trading on Aug. 20, 2024. Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. … Read more

Eli Lilly weight loss drug cuts risk of developing diabetes in trial

Eli Lilly weight loss drug cuts risk of developing diabetes in trial

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.  Shelby Knowles | Bloomberg | Getty Images Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with pre-diabetes compared to … Read more

Medicare releases prices for first 10 drugs subject to negotiations

Medicare releases prices for first 10 drugs subject to negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and … Read more

Eli Lilly, Novo Nordisk weight loss drugs

Eli Lilly, Novo Nordisk weight loss drugs

An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Novo Nordisk and Eli Lilly have so far dominated the booming market for a class of weight loss and diabetes drugs.  … Read more